Drugs / sodium dihydrogen phosphate dihydrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00493662 | — | dry eye syndrome | Innovative Medical | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03009604 Comparator | Jan → Apr 2017 | benign female reproductive system neoplasm | Assiut University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium dihydrogen phosphate dihydrate | “sodium dihydrogen phosphate dihydrate 19.2 gram” NCT03009604 ↗ |
| Known as | sodium phosphate monobasic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00493662 ↗ |